Determination and pharmacokinetic study of p-hydroxyphenethyl anisate following intravenous and oral administration in rats by RP-HPLC method

doi:10.5246/jcps.2020.11.073

Journal of Chinese Pharmaceutical Sciences ›› 2020, Vol. 29 ›› Issue (11): 804-812.DOI: 10.5246/jcps.2020.11.073

• Original articles • Previous Articles Next Articles

Determination and pharmacokinetic study of p-hydroxyphenethyl anisate following intravenous and oral administration in rats by RP-HPLC method

Xiuwei Yang^*, Youbo Zhang, Wei Xu

State Key Laboratory of Natural and Biomimetic Drugs and Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China

Received:2020-08-23 Revised:2020-09-18 Online:2020-11-30 Published:2020-10-07
Contact: Tel.: +86-10-82801569, E-mail: xwyang@bjmu.edu.cn
About author:Dr. Xiuwei Yang got his doctorate in Toyama Medical and Pharmaceutical University of Japan in 1992. He worked as a postdoctoral research fellow at School of Pharmaceutical Sciences from Beijing Medical University in 1992–1994. In 1994.9, he joined Peking University School of Pharmaceutical Sciences and worked as a professor. His major research interests are the absorption, distribution, metabolism, excretion, toxicity and activity of drugs (ADMET/Act.), complex system exploration of traditional Chinese Medicine, biological transformation of natural drug and/or Chinese medicinal chemical compositions, innovative drug discovery and natural medicinal chemistry.
Supported by:
The National Natural Science Foundation of China (Grant No. 30672609), National High Technology Research and Development Program of China (Grant No. 2002AA2Z343C, 2004AA2Z3783), National Sciences and Technology Program of China (Grant No. 2006BAI06A01-02), and Beijing Municipal Special-Purpose Science Foundation of China (Grant No. Z0004105040311).

Abstract

Abstract:

In the present study, we developed a rapid and specific reversed-phase high-performance liquid chromatographic (RP-HPLC) method for the quantification of p-hydroxyphenethyl anisate (HPA), one of the main bioactive constituents of the roots and rhizomes ofNotopterygium incisumand N. franchetii, in rat plasma after an intravenous (20 mg/kg, i.v.) and an intragastrical (200 mg/kg,i.g.) administration to rats, respectively. The method involved a plasma clear-up step using liquid-liquid extraction by EtOAc, followed by RP-HPLC separation and detection. Separation of HPAwas performed on an analytical Diamonsil^TMODS C₁₈ column with the mobile phase of MeOH–H₂O at ratios of 75:25 (v/v) for i.v. and 70:30 (v/v) for i.g. administration. The flow-rate was 1.0 mL/min, and UV detection was performed at 256 nm. The calibration curves were linear over the ranges of 0.05–5.0 μg/mL (r²= 0.9984) for i.v. and 0.5–10.0 μg/mL (r²= 0.9995) for i.g. administrationin rat plasma. The extraction recoveries were in the range of 82.01%–87.97%. The intra- and inter-day precisions were between 1.71% and 3.99%, with accuracies ranging from 91.22% to 110.5%. The absolute bioavailability of an orally administered HPA in rats was about 48.17%. The developed method was suitable for the determination and pharmacokinetic studyof HPA in rat plasma.

Key words: p-Hydroxyphenethyl anisate, Pharmacokinetic, Bioavailability, RP-HPLC, Notopterygium

CLC Number:

R969.1

Supporting:

Xiuwei Yang, Youbo Zhang, Wei Xu. Determination and pharmacokinetic study of p-hydroxyphenethyl anisate following intravenous and oral administration in rats by RP-HPLC method[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(11): 804-812.

References

[1] Wu, X.W.; Zhang, Y.B.; Zhang, L.; Yang, X.W. Simultaneous quantification of 33 active components in Notopterygii Rhizoma et Radix using ultra high performance liquid chromatography with tandem mass spectrometry. J. Chromatogr. B. 2018, 1092, 244-251.

[2] Wu, X.W.; Wei, W.; Yang, X.W.; Zhang, Y.B.; Xu, W.; Yang, Y.F.; Zhong, G.Y.; Liu, H.N.; Yang, S.L. Anti-inflammatory phenolic acid esters from the roots and rhizomes of notopterygium incisium and their permeability in the human caco-2 monolayer cell model. Molecules. 2017, 22, 935.

[3] Yang, X.W.; Gu, Z.M.; Wang, B.X.; Hattori, M.; Namba, T. Comparison of anti-lipid peroxidative effects of the underground parts of Notopterygium incisum and N. forbesii in mice. Planta Med. 1991, 57, 399-402.

[4] Qin, C.L.; Zhang, Y.; Liu, T.; Sun, Y.F.; Sun, Y.R.; Liu, H. Screening test on the active constituents of traditional Chinese medicine ―Qiang-Huo‖. China J. Chin. Mater. Med. 2000, 25, 639-640.

[5] Wu, X.W.; Yang, X.W. Coumarins from Notopterygium incisum and their inhibitory effect against lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells. Chin. Tradit. Herb. Drugs. 2020, 51, 3383-3392.

[6] Sun, Y.P.; Xu, Q. Effects of aqueous extract from Rhizoma Notopterygii on the delayed-type hypersensitivity and inflammatory reactions and its mechanisms. J. China Pharm. Univ. 2003, 34, 51-54.

[7] Gu, Z.M.; Zhang, D.X.; Yang, X.W.; Hattori, M.; Namba, T. Isolation of two new coumarin glycosides from Notopterygium forbesii and evaluation of a Chinese crude drug, Qiang-huo, the underground parts of N. incisum and N. forbesii, by high-performance liquid chromatography. Chem. Pharm. Bull. 1990, 38, 2498-2502.

[8] Zhan, W.C.; Zhou, Z.M.; Yu, W.F.; Xue, M. Synthesis of 4-hydroxyphenethyl anisate existing as an effective component in Notopterygium incisum Ting. J. Beijing Institute Technol. 2001, 21, 401-404.

[9] Yang, X.W.; Yan, Z.K.; Gu, Z.M.; Zou, G.C.; Masao, H.; Tsuneo, N. Studies on the chemical constituents of incised Notopterygium (Notopterygium incisum). Chin. Tradit. Herb. Drugs. 1993, 24, 507-511.

[10] Yang, X.W.; Yan, Z.K.; Gu Z.M.; Zou, G.C.; Masao, H.; Tsuneo, N. Studies on the chemical constituents of forbes Notopterygium (Notopterygium forbesii). Chin. Pharm. J. 1994, 29, 141-143.

[11] Zhang, P.; Yang, X.W. Studies on chemical constituents in roots and rhizomes of Notopterygium incisum. China J. Chin. Mater. Med. 2008, 33, 2918-2921.

[12] Li, Y.H.; Jiang, S.Y.; Guan, Y.L.; Liu, X.; Zhou, Y.; Li, L.M.; Huang, S.X.; Sun, H.D.; Peng, S.L.; Zhou, Y. Quantitative determination of the chemical profile of the plant material “Qiang-huo” by LC-ESI-MS-MS. Chromatographia. 2006, 64, 405-411.

[1]	Yanfang Yang, Wei Wei, Lei Zhang, Wei Xu, Xiuwei Yang. Simultaneous quantification of 37 constituents in Duliang Pill by UPLC-MS/MS: Application to the pharmacokinetic studies in rat plasma [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(7): 560-573.
[2]	Yingyuan Lu, Mei Zhang, Shengju Yin, Xiaona Dong, Zhiyuan Zhang, Haixu Cheng, Pengfei Tu, Guifang Dou, Yongsheng Che, Zhenghui Xu, Feng Xu, Xian Wang, Chuang Lu, Yaqing Lou, Guoliang Zhang. Epigenetic variants of xenobiotic metabolism affect individual differences in antiepileptic drug 3,4-DCPB pharmacokinetic phenotype [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(1): 1-16.
[3]	Yingzheng Wang, Ce Yang, Cuiping Zhu, Qianqian Zhao, Xuehua Lu, Xiaoyu Su, Yinghao Wang. Upper limb arthromyodynia can be treated with Notopterygium by down-regulating P2X3 to mediate PKC-induced inflammatory response [J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(3): 163-175.
[4]	Yanan Li, Xue Guo, Ye Yuan, Weichong Dong, Xiuling Yang. Determination of free ceftriaxone concentration and its application in predicting lung tissue concentration [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(7): 578-589.
[5]	Xiaojiao Li, Shuxin Luan, Hong Zhang, Hongquan Wan, Hong Chen, Chengjiao Liu, Chang Liu, Yanhua Ding. Pharmacokinetics, pharmacodynamics and safety of a single-dose long-acting Risperidone injection in Chinese patients with schizophrenia [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(3): 206-217.
[6]	Yan Zhou, Hengwen Song, Zhichao Shao, Bomin Yin, Ximei Fu, Dianyou Xie, Lijun Wei. Preclinical efficacy of a novel cyclin-dependent kinase 9 inhibitor, QHRD107 against acute myeloid leukemia [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(2): 146-156.
[7]	Ye Yuan, Bo Yu, Xueqin Zhang, Yanan Li, Shumei Wang. Effects of Zhenyuan capsule on the pharmacokinetics comparison of simvastatin and its active metabolites in rats [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(7): 494-503.
[8]	Jin Zhang, Weiwei Lin, Wei Wu, Xianzhong Guo, Pinfang Huang, Xinhua Lin, Zheng Jiao, Changlian Wang. Population pharmacokinetics of vancomycin in Chinese elderly patients and its application for dose individualisation [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(4): 260-271.
[9]	Xinyu Chang, Tao Guo, Guiming Guo . Effect of CYP3A4 genetic polymorphisms on pharmacokinetics of tinidazole [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(4): 272-279.
[10]	Shengxin Wang, Xiangli Yan, Haozhen Zheng, Jianye Yu, Aiming Yu, Xiao Shen, Lisheng Wang. Pharmacokinetics of different dosage of astragalus membranaceus of buyang huanwu decoction in rats with cerebral ischemic injury by microdialysis combined with LC/MS [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(2): 90-101.
[11]	Jingjing Cao, Jun Sun, Shujuan Zhao, Peizhi Ma. Pharmacological and clinical evaluation of a new anti-flu drug, baloxavir marboxil [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(10): 729-733.
[12]	Yajie Yin, Xiaofei Zhang, Zheng Cui, Wei Qu, Bing He, Wenbing Dai, Hua Zhang, Xueqing Wang, Qiang Zhang. In vitro dissolution and oral bioavailability study of fenofibrate nanomatrix system prepared by hot-melt extrusion [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(5): 329-338.
[13]	Hui Yang, Xiaopeng Hu, Xiongyong Yang, Hang Liu, Liang Ren, Wei Wang, Lihong Liu, Xiaodong Zhang. Pharmacokinetic interaction between glucocorticoids and tacrolimus after renal transplantation [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(4): 257-263.
[14]	Xin Liu, Bo Zhang, Dan Mei, Kai Huang. Rapid and sensitive HPLC-MS/MS method for quantitative determination of isochlorogenic acid B in rat plasma and its application in pharmacokinetic study [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(3): 167-173.
[15]	Zhengsheng Liu, Haijun Hao, Mingsong Fan. Quercetin-phospholipids complex solid dispersion and quercetin solid dispersion: preparation and evaluation [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(12): 868-877.

Determination and pharmacokinetic study of p-hydroxyphenethyl anisate following intravenous and oral administration in rats by RP-HPLC method

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments